BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25440818)

  • 21. Adverse prognostic significance of capsular incision with radical retropubic prostatectomy.
    Shuford MD; Cookson MS; Chang SS; Shintani AK; Tsiatis A; Smith JA; Shappell SB
    J Urol; 2004 Jul; 172(1):119-23. PubMed ID: 15201750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
    Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
    Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
    BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Clinical Impact of pT3a Lesions in Patients With pT3b Prostate Cancer Undergoing Radical Prostatectomy.
    Numbere N; Teramoto Y; Gurung PMS; Goto T; Yang Z; Miyamoto H
    Arch Pathol Lab Med; 2022 May; 146(5):619-625. PubMed ID: 34979562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate Cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System.
    Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
    Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.
    Manoharan M; Bird VG; Kim SS; Civantos F; Soloway MS
    BJU Int; 2003 Oct; 92(6):539-44. PubMed ID: 14511029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.
    Wheeler TM; Dillioglugil O; Kattan MW; Arakawa A; Soh S; Suyama K; Ohori M; Scardino PT
    Hum Pathol; 1998 Aug; 29(8):856-62. PubMed ID: 9712429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
    Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma.
    Cheng L; Darson MF; Bergstralh EJ; Slezak J; Myers RP; Bostwick DG
    Cancer; 1999 Nov; 86(9):1775-82. PubMed ID: 10547551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer.
    Gupta N; Bivalacqua TJ; Han M; Gorin MA; Challacombe BJ; Partin AW; Mamawala MK
    BJU Int; 2019 Aug; 124(2):268-274. PubMed ID: 30570825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer.
    Park CK; Chung YS; Choi YD; Ham WS; Jang WS; Cho NH
    Sci Rep; 2021 Jul; 11(1):13952. PubMed ID: 34230540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of extraprostatic extension by Grade Groups 1-3 prostatic carcinoma on needle biopsy.
    Zhao J; Epstein J
    Prostate; 2023 Jun; 83(8):809-813. PubMed ID: 36946608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.
    Kristiansen A; Drevin L; Delahunt B; Samaratunga H; Robinson D; Franck Lissbrant I; Stattin P; Egevad L
    Pathology; 2017 Dec; 49(7):715-720. PubMed ID: 29037803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.
    Kweldam CF; Kümmerlin IP; Nieboer D; Verhoef EI; Steyerberg EW; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ; van Leenders GJ
    Eur J Cancer; 2016 Oct; 66():26-33. PubMed ID: 27522247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
    DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
    Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does bilateral seminal vesicle invasion at radical prostatectomy predict worse prognosis than unilateral invasion among patients with pT3b prostate cancers?
    Lee HJ; Han JH; Lee DH; Nam JK; Kim TN; Chung MK; Park SW
    Int J Urol; 2016 Sep; 23(9):758-63. PubMed ID: 27305865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prognostic Factors of Biochemical Recurrence-Free Survival Following Radical Prostatectomy.
    Chalieopanyarwong V; Attawettayanon W; Kanchanawanichkul W; Pripatnanont C
    Asian Pac J Cancer Prev; 2017 Sep; 18(9):2555-2559. PubMed ID: 28952300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active Surveillance.
    Hassan O; Han M; Zhou A; Paulk A; Sun Y; Al-Harbi A; Alrajjal A; Baptista Dos Santos F; Epstein JI
    J Urol; 2018 Jun; 199(6):1482-1487. PubMed ID: 29154905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.